Avail Clinical Research Announces Teenage Smoking Cessation Research Studies in DeLand, Florida

Online, March 31, 2011 (Newswire.com) - DeLand, Florida- Avail Clinical Research, a privately owned research facility, founded in 1988 in DeLand, Florida, announces the launch of several research studies to test investigational treatment options for those already diagnosed with teenage Smoking Cessation. "Through clinical research studies, we can strive to significantly build on data previously conducted on those currently diagnosed with teenage smoking cessation," says Bruce G. Rankin, DO, CPI, the Medical Director and Principal Investigator at Avail Clinical Research since 1999. "Treatments for teenage smoking cessation are one of the research studies we are pleased to continue with at Avail Clinical Research. Our systemic evaluation clinical research trials are designed specifically to test the safety and efficacy of treatments for humans."

The research studies will enroll those already wanting help with teenage smoking cessation. Avail Clinical Research will take volunteers who:

- have a really strong desire to quit smoking (study is a year long and comes with counseling to help people quit permanently)
- willing to use a tobacco alternative (study offers a random selection of SNUS or lozenges as the tobacco alternative)
- are 12-17 years old
- are not obese
- do not have any of the following: Diabetes, HIV, Hep B, Hep C

Avail Clinical Research conducts clinical trials for diabetes, COPD, gout, OsteoArthritis and other conditions. Located in DeLand, Florida, near Orlando and Daytona Beach. Participation can include medical care.